Filing Flows › cbdMD (YCBD) › Q2 FY25
cbdMD (YCBD) Q2 FY25 earnings results (second quarter fiscal 2025)
10-Q filed May 15, 2025
cbdMD (YCBD) reported revenue of $4.7M for the second quarter fiscal 2025 (Q2 FY25), +9% from a year earlier and -7% from the quarter before. Operating margin was -10.2%, net loss $481K (10.1% of revenue).
cbdMD, Q2 FY25: revenue $4.7M (+8% year over year), operating margin -10.2%, net loss $481K, operating cash flow −$189K. The chart follows the revenue to costs, profit and cash.
| Q2 FY25 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $4.7M | -7% | +9% |
| Operating profit | −$486K | — | — |
| Net earnings | −$481K | — | — |
| Operating cash flow | −$189K | -213% | — |
What changed
Revenue was $4.7M in Q2 FY25, up 9% year over year and down 7% from the previous quarter.
Gross margin was 62.3%, up 3.3 points from a year earlier. Operating costs exceeded revenue by $486K, an operating margin of -10.2%. Operating expenses fell 17% while revenue rose 9%. The quarter ended with a net loss of $481K, after a profit of $15K the previous quarter.
Operating cash flow was −$189K. Non-cash charges added back $286K of depreciation and amortization. Capital expenditures of $16K exceeded it, leaving free cash flow of −$205K.
Questions
What was cbdMD's revenue in the second quarter fiscal 2025?
cbdMD (YCBD) reported revenue of $4.7M for the second quarter fiscal 2025 (Q2 FY25), +9% from a year earlier and -7% from the quarter before.
Was cbdMD profitable in the second quarter fiscal 2025?
Operating loss was $486K (-10.2% of revenue) and net loss $481K.
Source: cbdMD 10-Q on SEC EDGAR.